Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease

Potent inhibitors of the West Nile virus NS2B-NS3 protease could be useful drugs for the treatment of WNV infections. Therefore, in the present work, new substrate analogue inhibitors against the WNV protease have been developed. In this present work, new decarboxylated arginine memtics inhibitors...

全面介绍

Gespeichert in:
书目详细资料
主要作者: Hammamy, M. Zouhir
其他作者: Steinmetzer, Torsten (Prof. Dr.) (BetreuerIn (Doktorarbeit))
格式: Dissertation
语言:英语
出版: Philipps-Universität Marburg 2014
主题:
在线阅读:PDF-Volltext
标签: 添加标签
没有标签, 成为第一个标记此记录!
实物特征
总结:Potent inhibitors of the West Nile virus NS2B-NS3 protease could be useful drugs for the treatment of WNV infections. Therefore, in the present work, new substrate analogue inhibitors against the WNV protease have been developed. In this present work, new decarboxylated arginine memtics inhibitors against the WNV NS2B-NS3 protease were developed. In comparison to the known agmatine derivatives, the P1 trans-4-Guanidinocyclohexylmethylamid containing inhibitors have higher potency and selectivity against the WNV. Moreover, the first crystal structure of the WNV protease in complex with small noncovalently-binding inhibitor was solved.
DOI:10.17192/z2014.0245